Axiom an Active Participant at BIO Digital International Convention 2020
08 juin 2020 12h18 HE
|
Axiom Real-Time Metrics Inc
TORONTO, June 08, 2020 (GLOBE NEWSWIRE) -- Axiom Real-Time Metrics (“Axiom”), premier provider of unified eClinical solutions and services will have a significant delegate presence, be presenting,...
Cognition Therapeutics Receives $75.8 Million NIA Grant for 540-Patient Phase 2 Study of CT1812 in Collaboration with the Alzheimer's Clinical Trials Consortium
08 juin 2020 08h15 HE
|
Cognition Therapeutics, Inc.
New York, June 08, 2020 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc., a clinical stage neuroscience company focused on the protection and restoration of synaptic function in Alzheimer’s disease...
Clinical Trial Materials and Supplies Market Worth $25.9 Billion by 2027, Growing at a CAGR of 6% from 2019- Exclusive Report by Meticulous Research®
05 juin 2020 08h16 HE
|
Meticulous Market Research Pvt. Ltd.
London, June 05, 2020 (GLOBE NEWSWIRE) -- Clinical trials have a vigorous supply chain management of the drugs considering the stringency of the regulations and the availability of the...
Tempus Launches Prospective “Priority” Research Study and Increases Support for Oncology Research Initiatives Despite Pandemic Challenges
01 juin 2020 10h18 HE
|
Tempus
CHICAGO, June 01, 2020 (GLOBE NEWSWIRE) -- Tempus, a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare, today announces its...
Provectus Announces Presentation of Updated Data from Metastatic Uveal Melanoma Cohort of Phase 1 PV-10® Study at American Society of Clinical Oncology (ASCO) 2020 Virtual Scientific Program
01 juin 2020 09h00 HE
|
Provectus Biopharmaceuticals Inc.
Treatment refractory, immunologically cold, hepatic tumor type37% reduction and 83% stabilization of treated disease (2D-EASL)Overall survival of 11 months for checkpoint inhibition-naïve patients;...
Tempus’ TIME Trial™ Program Reaches Critical Scale and Operational Milestones
29 mai 2020 15h55 HE
|
Tempus
CHICAGO, May 29, 2020 (GLOBE NEWSWIRE) -- Tempus, a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare, has reached a...
Treos Bio Reports Positive Final Results of Phase I/II Off-The-Shelf CRC Cancer Immunotherapy in 2020 ASCO Poster Presentation
29 mai 2020 12h17 HE
|
Treos Bio Corp.
LONDON, May 29, 2020 (GLOBE NEWSWIRE) -- Treos Bio Limited, a clinical stage biopharma company developing precision peptide cancer immunotherapies, today presented positive final data from a Phase...
Axiom Presenting ‘A Global ePRO Case Study’ and Exhibiting at Outsourcing in Clinical Trials Virtual Experience Today
27 mai 2020 07h33 HE
|
Axiom Real-Time Metrics Inc
TORONTO, May 27, 2020 (GLOBE NEWSWIRE) -- Today Axiom Real-Time Metrics (“Axiom”), premier provider of unified eClinical solutions and services will be exhibiting and delivering a presentation...
Wave Life Sciences to Present at the Jefferies 2020 Virtual Healthcare Conference
26 mai 2020 16h05 HE
|
Wave Life Sciences USA, Inc.
CAMBRIDGE, Mass., May 26, 2020 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage genetic medicines company committed to delivering life-changing treatments for people...
APOLLOMICS（冠科美博）宣布启动C-MET抑制剂APL-101的II期全球多中心临床试验SPARTA
21 mai 2020 07h10 HE
|
Apollomics, Inc.
评估不分肿瘤类型的各种MET失调；聚焦MET 14号外显子跳跃突变的非小细胞肺癌及有MET扩增和融合的肿瘤，包括非小细胞肺癌，多形性胶质母细胞瘤及其他肿瘤 中国杭州市和美国福斯特市报道, May 21, 2020 (GLOBE NEWSWIRE) -- Apollomics,...